| Vial description: |
Betaglycan, TGFR-3, TGF-beta receptor type III |
| Category: |
primary antibody |
| Raised in: |
Rabbit |
| Clone: |
1 vial |
| Form: |
Affinity Purified |
| Reactivity: |
Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
Q03167 |
| Application: |
P |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
TGFBR3 (644-850) |
| Short name: |
anti-TGFBR3 (644-850) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
b receptor III (644-850) (Antibody to), antibody to-transforming growth factor |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
Extracellular, TGFBR3 and IDBG-100244 and ENSG00000069702 and 7049, TGFBR3 and IDBG-636658 and ENSBTAG00000024269 and 784894, Tgfbr3 and IDBG-186670 and ENSMUSG00000029287 and 21814, beta receptor III, betaglycan and BGCAN, this GO :0001568 and blood vessel development and biological process this GO :0001666 and response to hypoxia and biological process this GO :0001701 and in utero embryonic development and biological process this GO :0001824 and blastocyst development and biological process this GO :0001837 and epithelial to mesenchymal transition and biological process this GO :0001889 and liver development and biological process this GO :0003007 and heart morphogenesis and biological process this GO :0005024 and transforming growth factor beta-activated receptor activity and molecular function this GO :0005114 and type II transforming growth factor beta receptor binding and molecular function this GO :0005160 and transforming growth factor beta receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005539 and glycosaminoglycan binding and molecular function this GO :0005578 and proteinaceous extracellular matrix and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006461 and protein complex assembly and biological process this GO :0006955 and immune response and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007181 and transforming growth factor beta receptor complex assembly and biological process this GO :0008201 and heparin binding and molecular function this GO :0009897 and external side of plasma membrane and cellular component this GO :0009986 and cell surface and cellular component this GO :0010633 and negative regulation of epithelial cell migration and biological process this GO :0010719 and negative regulation of epithelial to mesenchymal transition and biological process this GO :0015026 and coreceptor activity and molecular function this GO :0016049 and cell growth and biological process this GO :0016477 and cell migration and biological process this GO :0017134 and fibroblast growth factor binding and molecular function this GO :0030165 and PDZ domain binding and molecular function this GO :0030509 and BMP signaling pathway and biological process this GO :0030511 and positive regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0030512 and negative regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0031100 and organ regeneration and biological process this GO :0032354 and response to follicle-stimulating hormone and biological process this GO :0034673 and inhibin-betaglycan-ActRII complex and cellular component this GO :0034695 and response to prostaglandin E and biological process this GO :0034699 and response to luteinizing hormone stimulus and biological process this GO :0035556 and intracellular signal transduction and biological process this GO :0043393 and regulation of protein binding and biological process this GO :0046332 and SMAD binding and molecular function this GO :0048185 and activin binding and molecular function this GO :0050431 and transforming growth factor beta binding and molecular function this GO :0050680 and negative regulation of epithelial cell proliferation and biological process this GO :0051092 and positive regulation of NF-kappaB transcription factor activity and biological process this GO :0051271 and negative regulation of cellular component movement and biological process this GO :0055010 and ventricular cardiac muscle tissue morphogenesis and biological process this GO :0060021 and palate development and biological process this GO :0060038 and cardiac muscle cell proliferation and biological process this GO :0060216 and definitive hemopoiesis and biological process this GO :0060317 and cardiac epithelial to mesenchymal transition and biological process this GO :0060318 and definitive erythrocyte differentiation and biological process this GO :0060347 and heart trabecula formation and biological process this GO :0060389 and pathway-restricted SMAD protein phosphorylation and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070123 and transforming growth factor beta receptor activity, this GO :0005024 : transforming growth factor beta-activated receptor activity, this GO :0005024 : transforming growth factor beta-activated receptor activity and also this GO :0005114 : type II transforming growth factor beta receptor binding and also this GO :0005160 : transforming growth factor beta receptor binding and also this GO :0005515 : protein binding and also this GO :0005539 : glycosaminoglycan binding and also this GO :0008201 : heparin binding and also this GO :0015026 : coreceptor activity and also this GO :0017134 : fibroblast growth factor binding and also this GO :0030165 : PDZ domain binding and also this GO :0046332 : SMAD binding and also this GO :0048185 : activin binding and also this GO :0050431 : transforming growth factor beta binding and also this GO :0070123 : transforming growth factor beta receptor activity, this GO :0005114 : type II transforming growth factor beta receptor binding, this GO :0005160 : transforming growth factor beta receptor binding, this GO :0005515 : protein binding, this GO :0005539 : glycosaminoglycan binding, this GO :0008201 : heparin binding, this GO :0015026 : coreceptor activity, this GO :0017134 : fibroblast growth factor binding, this GO :0030165 : PDZ domain binding, this GO :0046332 : SMAD binding, this GO :0048185 : activin binding, this GO :0050431 : transforming growth factor beta binding, this GO :0070123 : transforming growth factor beta receptor activity, transforming growth factor beta receptor activity, type III, type III, type III and molecular function, transforming growth factor |
| Identity: |
11774 |
| Gene: |
TGFBR3 |
More about : TGFBR3 |
| Long gene name: |
transforming growth factor beta receptor 3 |
| Synonyms gene name: |
beta receptor III transforming growth factor beta receptor III , transforming growth factor |
| Synonyms: |
betaglycan BGCAN |
| Synonyms name: |
betaglycan proteoglycan |
| Locus: |
1p22, 1 |
| Discovery year: |
1993-09-30 |
| GenBank acession: |
L07594 |
| Entrez gene record: |
7049 |
| Pubmed identfication: |
1333192 1319842 |
| RefSeq identity: |
NM_003243 |
| Classification: |
Proteoglycans |
| Havana BLAST/BLAT: |
OTTHUMG00000010097 |